Dr. Paul Sax weighs in on a newly approved antibiotic in
HIV and ID Observations.
In the latest HIV and ID Observations, Dr. Paul Sax discusses the FDA approval of eravacycline, a tetracycline derivative but with a much broader antibacterial spectrum.
Want to see more from NEJM Journal Watch? Register here.